Optimization of Chromone-2-carboxamide Melanin Concentrating Hormone Receptor 1 Antagonists: Assessment of Potency, Efficacy, and Cardiovascular Safety
- 29 September 2006
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (22), 6569-6584
- https://doi.org/10.1021/jm060683e
Abstract
Evaluation of multiple structurally distinct series of melanin concentrating hormone receptor 1 antagonists in an anesthetized rat cardiovascualar assay led to the identification of a chromone-2-carboxamide series as having excellent safety against the chosen cardiovascular endpoints at high drug concentrations in the plasma and brain. Optimization of this series led to considerable improvements in affinity, functional potency, and pharmacokinetic profile. This led to the identification of a 7-fluorochromone-2-carboxamide (22) that was orally efficacious in a diet-induced obese mouse model, retained a favorable cardiovascular profile in rat, and demonstrated dramatic improvement in effects on mean arterial pressure in our dog cardiovascular model compared to other series reported by our group. However, this analogue also led to prolongation of the QT interval in the dog that was linked to affinity for hERG channel and unexpectedly potent functional blockade of this ion channel.Keywords
This publication has 15 references indexed in Scilit:
- Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese miceEuropean Journal of Pharmacology, 2006
- Discovery of Orally Efficacious Melanin-Concentrating Hormone Receptor-1 Antagonists as Antiobesity Agents. Synthesis, SAR, and Biological Evaluation of Bicyclo[3.1.0]hexyl UreasJournal of Medicinal Chemistry, 2006
- Chronic intracerebroventricular infusion of MCH causes obesity in miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague–Dawley ratsInternational Journal of Obesity, 2002
- DR's orders: Human antibody kills tumors by direct signalingNature Medicine, 2002
- T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonistEuropean Journal of Pharmacology, 2002
- Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistanceJCI Insight, 2001
- Melanin-concentrating Hormone Receptor: An Orphan Receptor Fits the KeyTrends in Endocrinology & Metabolism, 2000
- Central nervous system control of food intakeNature, 2000
- Mice lacking melanin-concentrating hormone are hypophagic and leanNature, 1998